Kojamo Oyj (LON:0A0E)
10.44
-0.03 (-0.27%)
At close: Nov 5, 2025
Kojamo Oyj Revenue
Kojamo Oyj had revenue of 113.60M EUR in the quarter ending September 30, 2025, with 0.35% growth. This brings the company's revenue in the last twelve months to 457.20M, up 1.04% year-over-year. In the year 2024, Kojamo Oyj had annual revenue of 452.40M with 2.28% growth.
Revenue (ttm)
457.20M EUR
Revenue Growth
+1.04%
P/S Ratio
5.57
Revenue / Employee
1.87M EUR
Employees
245
Market Cap
2.22B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 452.40M | 10.10M | 2.28% |
| Dec 31, 2023 | 442.30M | 28.90M | 6.99% |
| Dec 31, 2022 | 413.40M | 21.60M | 5.51% |
| Dec 31, 2021 | 391.80M | 7.70M | 2.00% |
| Dec 31, 2020 | 384.10M | 8.60M | 2.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.03B |